ScholarIQanswers from OpenAlex & ORCID
James R. Jett
ResearcherPublications, citations & collaboration network
James R. Jett is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does James R. Jett have?
ScholarIQindexed works
James R. Jett has 378 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does James R. Jett have?
ScholarIQcitation count
James R. Jett has 29,357 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of James R. Jett?
ScholarIQh-index
James R. Jett has an h-index of 78 in OpenAlex.
What is the i10-index of James R. Jett?
ScholarIQi10-index
James R. Jett has an i10-index of 217 in OpenAlex.
What is the OpenAlex record for James R. Jett?
ScholarIQopenalex
The OpenAlex for James R. Jett is on the source record.
What are the most-cited papers on James R. Jett?
ScholarIQmost cited works
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
William D. Travis, Élisabeth Brambilla, Masayuki Noguchi, Andrew G. Nicholson, Kim R. Geisinger, Yasushi Yatabe, David G. Beer, Charles A. Powell, Gregory J. Riely, Paul E. Van Schil, Kavita Garg, John H. M. Austin, Hisao Asamura, Valerie W. Rusch, Fred R. Hirsch, Giorgio V. Scagliotti, Tetsuya Mitsudomi, Rudolf M. Huber, Yuichi Ishikawa, James R. Jett, Montse Sánchez‐Céspedes, Jean‐Paul Sculier, Takashi Takahashi, Masahiro Tsuboi, Johan Vansteenkiste, Ignacio I. Wistuba, Pan‐Chyr Yang, Denise R. Aberle, Christian Brambilla, Douglas B. Flieder, Wilbur A. Franklin, Adi F. Gazdar, Michael K. Gould, P S Hasleton, Douglas W. Henderson, Bruce Johnson, David Johnson, Keith M. Kerr, Keiko Kuriyama, Jin Soo Lee, Vincent A. Miller, Iver Petersen, Victor L. Roggli, Rafael Rosell, Nagahiro Saijo, Erik Thunnissen, Ming‐Sound Tsao, David Yankelewitz
The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups
Michael T. Jaklitsch, Francine L. Jacobson, John H. M. Austin, John K. Field, James R. Jett, Shaf Keshavjee, Heber MacMahon, James L. Mulshine, Reginald F. Munden, Ravi Salgia, Gary M. Strauss, Steven Swanson, William D. Travis, David J. Sugarbaker
Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study
Glenwood Goss, Chris J. O’Callaghan, Ian Lorimer, Ming‐Sound Tsao, Gregory A. Masters, James R. Jett, Martin J. Edelman, Rogério Lilenbaum, Hak Choy, Fadlo R. Khuri, Katherine M.W. Pisters, David R. Gandara, Kemp H. Kernstine, Charles Butts, Jonathan Noble, Thomas A. Hensing, Kendrith M. Rowland, Joan H. Schiller, Keyue Ding, Frances A. Shepherd